Central Nervous System
- A Phase III randomized, double-blind, placebo-controlled, multi-center study of an oral drug in patients with multiple sclerosis
- A Phase III open label, treatment continuation study of an oral drug in patients with multiple sclerosis
- Statistical support for publications and design and analysis of Phase IV studies for the treatment of relapsing/remitting multiple sclerosis (RRMS)